Delivery Order SPE2DB20D3303-SPE2DB24FA1NA

Award Date 7/29/24
Potential Completion Date 7/30/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution services company. The order, valued at $5,308.44, is for the supply of Rexulti 2 mg tablets. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
This is a firm fixed price delivery order valued at $15,348.61 awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Rexulti 3 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product Rexulti 1 mg tablet in quantities of 30s. The award has a ceiling value of $4,457.98 and a completion date of August 27, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, as the prime contractor. The contract is for the supply of 4,563,982,168 tablets of the pharmaceutical product Rexulti 1 mg. The delivery order has a firm fixed price of $2,656.00 and a completion date of March 18, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December...
This is a $10,492.64 firm fixed-price delivery order awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corporation's Corporate Office Division. The order is for 4,565,862,250 tablets of the pharmaceutical Rexulti 1 mg, which is used to treat certain mental health conditions. There is no set-aside designation for this award. AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of essential medical products, including specialty medications, vaccines,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $30,591.65, is for the supply of Rexulti 1 mg tablets, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
This is a delivery order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with the Defense Logistics Agency (DLA) Troop Support Medical. The $4,649.70 delivery order is for the supply of Rexulti 2 mg tablets, a brand-name prescription medication. The contract has a firm fixed price and an ultimate completion date of May 13, 2024. This delivery order is part of a larger $999,999,999 IDC between AmerisourceBergen and the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Rexulti (1 mg tablets). The contract has a firm fixed price of $15,826.01 and an ultimate completion date of July 31, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Rexulti 0.5 mg tablet. The $13,088.31 firm fixed-price contract has an ultimate completion date of August 20, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation for this award. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999...
This is a $9,062.41 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4565873440 REXULTI 1 MG tablet prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen and DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and medical supplies to...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA1NA
    Delivery Order

This $10,959.63 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which does not have a set-aside designation. The order is expected to be completed by July 30, 2024.

Generated 10/28/24, 10:01 AM